Trial Profile
Evaluation of Effectiveness and Safety of Levemir (Insulin Detemir), NovoMix (Biphasic Insulin Aspart) and/or NovoRapid (Insulin Aspart) in Insulin naive Subjects With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novo Nordisk
- 21 Dec 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 09 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 09 Jul 2010 Actual patient number (10408) added as reported by ClinicalTrials.gov.